(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXACTMEDS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

EXACTMEDS

ST13

US500000090694071

Class

44

Filing

90694071

Registration

6862357

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

18

Latest update

04/21/2023

Trademark type

Word

Nice classes

44

Filing date

05/06/2021

Registration date

10/04/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/04/2022

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

04/30/2021

First use in commerce

04/30/2021

Drawing code

4

Owner type

16

Owner location

Franklin, TN

Examiner

MALYSZEK, KIMBERLY

Law office

N40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

RxGenomix, LLC

Representatives

Robert W. Coykendall MORRIS, LAING, EVANS, BROCK & KENNEDY, CHTD

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

DNA screening for medical purposesspecifically for the purpose of individuals response to medications in order to selectcalibrate individual medication dosagesdetermine the sequence and timing of the dosages excluding diagnostic and screening tests and laboratory services for disease or predisease detectionmonitoring or surveillance

Publications

History of USPTO decisions and trademark events.

18 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/04/2022

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

08/25/2022

CHPB

POST PUBLICATION AMENDMENT - ENTERED

08/02/2022

APET

ASSIGNED TO PETITION STAFF

08/01/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

07/14/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

03/07/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/15/2022

PUBO

PUBLISHED FOR OPPOSITION

02/15/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/26/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/12/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

01/12/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/12/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

01/12/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/12/2022

DOCK

ASSIGNED TO EXAMINER

01/10/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/10/2021

NWAP

NEW APPLICATION ENTERED

05/10/2021

Continuous trademark protection

Get notified about every new filing that threatens EXACTMEDS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.